Evolution from small molecule to nano-drug delivery systems: An emerging approach for cancer therapy of ursolic acid
2020 · Asian Journal of Pharmaceutical Sciences · 59 citations
https://doi.org/10.1016/j.ajps.2020.03.001
X
Xiaotian Yuan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
46
Papers
1.8K
Citations
21
h-index
29
i10-index
Xiaotian Yuan is an academic researcher from University Health Network. The author has contributed to research in topics: Epigenetics and DNA Methylation & Telomeres, Telomerase, and Senescence & Bladder and Urothelial Cancer Treatments. The author has an h-index of 21, co-authored 40 publications.
ORCID: 0000-0002-1501-518XPapers by this author
worksHistone Chaperone ASF1A Predicts Poor Outcomes for Patients With Gastrointestinal Cancer and Drives Cancer Progression by Stimulating Transcription of β-Catenin Target Genes
2017 · EBioMedicine · 29 citations
https://doi.org/10.1016/j.ebiom.2017.06.007
GABPA-activated TGFBR2 transcription inhibits aggressiveness but is epigenetically erased by oncometabolites in renal cell carcinoma
2022 · Journal of Experimental & Clinical Cancer Research · 27 citations
https://doi.org/10.1186/s13046-022-02382-6
Potential mechanism of pyrotinib-induced diarrhea was explored by gut microbiome and ileum metabolomics
2022 · Anti-Cancer Drugs · 8 citations
https://doi.org/10.1097/cad.0000000000001440
Clinical characteristics and prognostic factors of patients with non-small cell lung cancer having HER2 alterations
2022 · Journal of Cancer Research and Clinical Oncology · 5 citations
https://doi.org/10.1007/s00432-022-04196-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat